Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation.
about
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overviewEpigenetic mechanisms in cardiac development and disease"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant resultsMesp1 Marked Cardiac Progenitor Cells Repair Infarcted Mouse Hearts.CIBZ Regulates Mesodermal and Cardiac Differentiation of by Suppressing T and Mesp1 Expression in Mouse Embryonic Stem Cells.The roles of Mesp family proteins: functional diversity and redundancy in differentiation of pluripotent stem cells and mammalian mesodermal developmentDisturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmiasOVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.Genetic networks governing heart development.High glucose suppresses embryonic stem cell differentiation into cardiomyocytes : High glucose inhibits ES cell cardiogenesisGeneration of PDGFRα+ Cardioblasts from Pluripotent Stem Cells.Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cellsCardiac cell lineages that form the heart.Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability.ER71 directs mesodermal fate decisions during embryogenesisIdentification of novel long noncoding RNAs underlying vertebrate cardiovascular development.Simulated Microgravity Exerts an Age-Dependent Effect on the Differentiation of Cardiovascular Progenitors Isolated from the Human HeartThree-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells.Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac DifferentiationNKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets.Braveheart, a long noncoding RNA required for cardiovascular lineage commitmentMESP1 Mutations in Patients with Congenital Heart Defects.Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined FactorsHow Mesp1 makes a move.Nkx2-5 mediates differential cardiac differentiation through interaction with Hoxa10.Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions.CITED2 Cooperates with ISL1 and Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells.Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons.Optimizing mesoderm progenitor selection and three-dimensional microniche culture allows highly efficient endothelial differentiation and ischemic tissue repair from human pluripotent stem cells.Dpath software reveals hierarchical haemato-endothelial lineages of Etv2 progenitors based on single-cell transcriptome analysis.Islet1-expressing cardiac progenitor cells: a comparison across species.From pluripotency to distinct cardiomyocyte subtypes.Concise review: The role of C-kit expressing cells in heart repair at the neonatal and adult stage.The functional diversity of essential genes required for mammalian cardiac development.The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology.An inducible expression system of the calcium-activated potassium channel 4 to study the differential impact on embryonic stem cells.Concise Review: Fluorescent Reporters in Human Pluripotent Stem Cells: Contributions to Cardiac Differentiation and Their Applications in Cardiac Disease and Toxicity.Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative MedicineQuantitative Assessment of Sialo-Glycoproteins and N-Glycans during Cardiomyogenic Differentiation of Human Induced Pluripotent Stem Cells.
P2860
Q24618089-C3425956-8888-40CA-A3FC-DC4601353B5BQ26853290-8F093438-9107-4A3E-ACDB-B299FFFBA941Q26859990-3EF6582D-7652-475E-BA4D-ADD7831E0573Q27318072-517188B9-17D9-47FD-B06A-B677D5F0FAEEQ27342309-94E5ED21-F44A-4D19-8732-690BEDA70D64Q28083681-349ACA23-E323-4A7B-ABF4-04B507BF41A3Q28648466-331C46CF-99D6-405C-B931-DA19ED058AE0Q30366308-49582D60-CCB0-4A62-B236-3847E44F0573Q30367427-DBEEA624-DCA8-42E0-9422-2C5721334559Q30831503-3C1DFAA2-1524-4385-B74B-F032213A0E9CQ30837641-86879A6B-25AF-4F0A-8D5F-605687AC3718Q34053605-68804EFF-2575-40BE-A5FF-BCC31ED162D7Q34083167-4C82931A-CB89-4365-B8B3-567BC3F01E07Q35035279-E41690BA-A163-4702-A2EF-03AEF0BF899FQ35306113-B46CFE79-C22F-4252-A6C5-98093043E51EQ35646709-1BD6884B-9ED8-4B0F-9377-EF1FAB5A7576Q35687932-04EAA521-E80E-4C6B-BA26-DB7637A86C41Q35763591-55C1AB14-234A-40D9-AD6C-9BE98EC96583Q35824690-14B18422-7289-4F3E-8EAE-354F97191CCFQ35873200-479CE39E-4016-45E4-A07F-F3567DA380E5Q35992694-CDEB1B8C-7493-4709-BF91-2D6D9979EE3CQ36585810-00B76642-A3DC-4AB1-A7E6-E2317CAF11EDQ36604344-B85D2153-82E4-482A-A02A-DC9F4C644C19Q36654906-6580EDD4-7D5D-46DB-BEE1-DB3CE2FFB95EQ36929958-CD15788F-F21B-47BD-895B-7E9CFD5F7A5BQ37025687-ADDA6EC0-EAF2-435B-90AE-58DA5107414DQ37172409-B404446F-3917-4ADB-867F-3533BE42B6C7Q37510379-BA211EEE-3C11-4F43-8FFA-797A4C5C0E03Q37551594-AE9AE751-928C-450C-AAE1-3BC25C44FEFAQ37602402-139873F2-A6E5-4180-A0BB-B09F32C29062Q37642701-02816611-DB5B-4BA3-9087-BA24DAAD9E73Q38004839-B364FA88-5CE3-4C28-90B9-A9885BEB7221Q38018022-CF842CA4-F3F4-41BB-8665-B56969B979C9Q38192565-09E52945-FECF-4860-A83A-1CE174A00F60Q38215321-D8E8BD43-1D86-4C25-AA87-92BCEADC8F08Q38258288-4393573D-CB54-4C6A-ADF8-3A52CDF9EF99Q38445575-C5F6766F-6751-481E-A09C-36049CE0DCE6Q38601752-6C0FA778-7255-4D92-8854-781293DAB23CQ38657334-55014AAC-C196-4DA3-82C5-A0094787E661Q38683295-B6C3DFA9-ADC7-4D7A-A995-6119E39A5505
P2860
Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Defining the earliest step of ...... nic stem cell differentiation.
@ast
Defining the earliest step of ...... nic stem cell differentiation.
@en
Defining the earliest step of ...... nic stem cell differentiation.
@nl
type
label
Defining the earliest step of ...... nic stem cell differentiation.
@ast
Defining the earliest step of ...... nic stem cell differentiation.
@en
Defining the earliest step of ...... nic stem cell differentiation.
@nl
prefLabel
Defining the earliest step of ...... nic stem cell differentiation.
@ast
Defining the earliest step of ...... nic stem cell differentiation.
@en
Defining the earliest step of ...... nic stem cell differentiation.
@nl
P2093
P2860
P356
P1476
Defining the earliest step of ...... nic stem cell differentiation.
@en
P2093
Antoine Bondue
Benjamin Beck
Catherine Paulissen
Cédric Blanpain
Giuseppe Chiapparo
Richard Harvey
Samira Chabab
Simon Tännler
P2860
P304
P356
10.1083/JCB.201007063
P407
P577
2011-03-01T00:00:00Z